MEDIAIRE MEETS MOVEMBER
YOUR AI FOR THE EVALUATION OF PROSTATE MRIs
- Fully-automated PI-RADS 2.1 lesion classification
- Quantitative report including lesion sector map
- For differential diagnostics and follow ups
- PACS integration and connection to fusion biopsy
Automated active surveillance of the prostate
With over 470,000 new cases each year in Europe, prostate cancer is the most common cancer diagnosis among men. The Movember initiative highlights the importance of early detection and close monitoring — a cause that we at mediaire fully support.
Our AI tool offers automated active surveillance through precise comparisons with previous findings and PI-RADS 2.1 classification of lesions using mpMRI, along with many other features.
Partner Die Radiologie Munich
Professor LMU Munich
Partner Die Radiologie Munich
Professor LMU Munich
Proven high diagnostic quality
Published, independent study shows how mdprostate improves the work of radiologists in tumor detection and classification.
86%
proven sensitivity at a PI-RADS threshold of ≥4 compared to the histological ground truth
Automated visualization of all lesions (>= PI-RADS 3) in a schematic sector map
Tabular overview of all relevant lesion metrics and the PI-RADS scores of the current and previous examinations
Fully-automated prostate segmentation
Our tool automatically calculates the prostate volume, segments the regions according to PI-RADS 2.1 and simplifies your workflow significantly. Optionally, the PSA density can be calculated.
Fully-automated lesion classification (PI-RADS 2.1)
Get a detailed evaluation of classified lesions with clear information about volume, dimensions, ADC values and other parameters.
First AI-tool with longitudinal assessments for the prostate
Experience the first AI-based prostate tool with longitudinal assessments. Easily compare the previous assessment with the current one, integrated into one report (available from version 1.3).
Customise reports quickly and easily for optimal results
While our AI-tool is there to support, you drive the final decision. You have the option to adjust, in case you'll ever need it. Reports only leave the workstation how and when you want to.
PROSTATE DIAGNOSIS WITH OUR
INNOVATIVE AI WORKFLOW
RADIOLOGIST
MDPROSTATE MEETS MOVEMBER - START YOUR FREE TRIAL NOW
As part of our Movember campaign, we are offering you a three-month free and non-binding trial of mdprostate. Simply register here and our experts will reach out to you directly afterwards.
FAQ
mdbrain and mdprostate are approved as medical devices within the European Union and bear the CE marking. This means that the AI solutions can be used for patients across Europe and are partially reimbursable in accordance with local regulations.
mdbrain and mdprostate can seamlessly work with all DICOM data from standard MRI systems from Siemens, Philips, GE, or Canon/Toshiba with 1.5 or 3T field strength. Even though both solutions can work with a wider range of image qualities, we recommend specifications for optimal results.
mdprostate
- T2w Spin Echo (SE) with a resolution of at least 0.9 x 0.9 mm², DWI (all) with a resolution of at least 2.5 x 2.5 mm² with a B-value between 1400 and 2000 (measured or calculated), and ADC with a resolution of at least 2.5 x 2.5 mm².
- We recommend using a 2D T2, as there are no 3D T2 cases included in the training data.
- The evaluation of the dynamic contrast-enhanced sequence (DCE) is optional and must be accepted by the user via the browser interface. If the use of the browser interface is not desired or possible, mdprostate will only use the above-mentioned sequences (native) unchanged. Specifications for the DCE series: T1 GRE, axial, and the entire sequence must be created and available as a single series. mdprostate cannot evaluate DCE as a multi-series.
mdbrain
Brain volumetry: 3D-T1-MPRAGE sequence with an in-plane resolution of at least 1.0 x 1.0 mm².
Lesion characterization: (3D-)T1 sequence and 3D-T2-FLAIR sequence, both with an in-plane resolution of 1.0 x 1.0 mm².
Aneurysm detection: TOF sequence with an in-plane resolution of 1.0 x 1.0 mm².
Tumor differentiation: 3D-T1 sequence with an in-plane resolution of 1.0 x 1.0 mm², 3D-T2-FLAIR sequence with an in-plane resolution of 1.0 mm x 1.0 mm, T1 sequence with contrast medium with an in-plane resolution of 3.0 x 3.0 mm² and T2-Spin-Echo sequence with an in-plane resolution of 3.0 x 3.0 mm².
For testing our software, we offer two options: an online demo and an on-premise installation. The online demo is a free, web-based testing opportunity and can be requested by simply registering at this link. For the option of an on-premise test, please contact us at info@mediaire.de so that our sales and support team can provide you with the individual conditions for testing.
The md-suite, including the software solutions mdbrain and mdprostate, is installed locally in your practice/hospital and can be seamlessly integrated into your PACS. The system requirements are reasonable: A Linux or Ubuntu system with an Intel i7 processor, at least 4 cores, 16GB RAM, and 500GB HDD is sufficient in most cases for smooth analysis. The analysis time can be significantly reduced with the use of a graphics card. We are happy to provide more detailed specifications to your local IT and of course, we are ready to assist with the installation.
The solutions mdbrain and mdprostate are billed according to a Software as a Service (SaaS) model. This means you do not need to purchase the software outright and only pay for as many analyses as you actually use. Additionally, you automatically benefit from future product improvements and expanded functionality. The usage fee depends on the monthly volume of examinations. In addition, we charge a one-time installation fee and a monthly service fee. You achieve the optimal cost-benefit ratio with full automation.
- Auto-Pull: Automatic check for previously unevaluated studies
- Auto-Routing: Automatic forwarding of specific studies to the md-suite server
- Longi-Pull: Automatic inclusion of prior scans for longitudinal evaluation
- Auto-Send: Automatic integration of all results in your PACS
The mediaire software solutions mdbrain and mdprostate are part of the md-suite, a closed system integrated within your local IT workflow, ensuring utmost confidentiality. At no point do patient data or reports leave your premises. Therefore, anonymization is not necessary.
The data and reports never leave your practice/hospital, not even in anonymized form. Mediaire's software solutions are specifically designed to ensure the highest level of data protection for patients by keeping all patient information, analysis processes, and reports stored locally in your practice/hospital.
